Smoking cessation interventions for adults aged 50 or older: A systematic review and meta-analysis.

dc.contributor.author

Chen, Danhong

dc.contributor.author

Wu, Li-Tzy

dc.date.accessioned

2020-02-03T05:27:19Z

dc.date.available

2020-02-03T05:27:19Z

dc.date.issued

2015-09

dc.date.updated

2020-02-03T05:27:18Z

dc.description.abstract

The older population size has increased substantially, and a considerable proportion of older adults are cigarette smokers. Quitting smoking is associated with reduced health risk. This review is among the first to quantitatively assess the relative efficacy of types of cessation interventions for smokers aged ≥50 years.We conducted searches of the Cochrane Library, Embase, MEDLINE, and PsycINFO to identify smoking cessation studies on adults aged ≥50 years. Twenty-nine randomized clinical trials met the inclusion criteria. Three main types of interventions were identified. We analyzed relative cessation rates or Risk Ratios (RRs) between the type of intervention groups and the control group by fixed- and random-effects meta-analyses at the study level. We conducted a weighted least squares meta-regression of cessation rates on trial and sample characteristics to determine sources of outcome heterogeneity.Fixed-effects analysis showed significant treatment effects for pharmacological (RR=3.18, 95% CI: 1.89-5.36), non-pharmacological (RR=1.80, 95% CI: 1.67-1.94), and multimodal interventions (RR=1.61, 95% CI: 1.41-1.84) compared with control group. Estimations based on meta-regression suggested that pharmacological intervention (mean point prevalence abstinence rate (PPA)=26.10%, CI: 15.20-37.00) resembled non-pharmacological (27.97%, CI: 24.00-31.94), and multimodal interventions (36.64%, CI: 31.66-41.62); and non-pharmacological and multimodal interventions had higher PPAs than the control group (18.80%, CI: 14.48-23.12), after adjusting for a number of trial and sample characteristics.A small number of smoking cessation studies examined smokers aged ≥50 years. Additional research is recommended to determine smoking cessation efficacy for diverse older population groups (e.g., ethnic minorities).

dc.identifier

S0376-8716(15)00298-7

dc.identifier.issn

0376-8716

dc.identifier.issn

1879-0046

dc.identifier.uri

https://hdl.handle.net/10161/19975

dc.language

eng

dc.publisher

Elsevier BV

dc.relation.ispartof

Drug and alcohol dependence

dc.relation.isversionof

10.1016/j.drugalcdep.2015.06.004

dc.subject

Humans

dc.subject

Combined Modality Therapy

dc.subject

Odds Ratio

dc.subject

Smoking

dc.subject

Smoking Cessation

dc.subject

Age Factors

dc.subject

Middle Aged

dc.title

Smoking cessation interventions for adults aged 50 or older: A systematic review and meta-analysis.

dc.type

Journal article

duke.contributor.orcid

Wu, Li-Tzy|0000-0002-5909-2259

pubs.begin-page

14

pubs.end-page

24

pubs.organisational-group

School of Medicine

pubs.organisational-group

Duke

pubs.organisational-group

Center for Child and Family Policy

pubs.organisational-group

Sanford School of Public Policy

pubs.organisational-group

Duke Clinical Research Institute

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Duke Institute for Brain Sciences

pubs.organisational-group

University Institutes and Centers

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

Psychiatry & Behavioral Sciences, Social and Community Psychiatry

pubs.organisational-group

Psychiatry & Behavioral Sciences

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Medicine, General Internal Medicine

pubs.organisational-group

Medicine

pubs.publication-status

Published

pubs.volume

154

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Chen 2015 Smoking cessation interventions for adults aged 50 or older A systematic review and meta-analysis..pdf
Size:
795.28 KB
Format:
Adobe Portable Document Format